C57BL/6JCya-Men1em1/Cya
Common Name
Men1-KO
Product ID
S-KO-15795
Backgroud
C57BL/6JCya
Strain ID
KOCMP-17283-Men1-B6J-VA
When using this mouse strain in a publication, please cite “Men1-KO Mouse (Catalog S-KO-15795) were purchased from Cyagen.”
Product Type
Age
Genotype
Sex
Quantity
Basic Information
Strain Name
Men1-KO
Strain ID
KOCMP-17283-Men1-B6J-VA
Gene Name
Product ID
S-KO-15795
Gene Alias
-
Background
C57BL/6JCya
NCBI ID
Modification
Conventional knockout
Chromosome
Chr 19
Phenotype
Datasheet
Application
--
Strain Description
Ensembl Number
ENSMUST00000056391
NCBI RefSeq
NM_008583
Target Region
Exon 2~5
Size of Effective Region
~1.5 kb
Overview of Gene Research
Men1, encoding a 610-amino acid protein menin, is a tumor suppressor gene [1]. Mutations in Men1 lead to multiple endocrine neoplasia type 1 (MEN1), an autosomal dominant disorder. Menin interacts with transcription factors and chromatin-modifying proteins in cell signaling pathways such as transforming growth factor β/bone morphogenetic protein, Wnt/β-catenin, and Hedgehog, facilitating the understanding of MEN1-associated tumor pathogenesis [3].
Mouse models of MEN1, with loss-of-function mutations in the Men1 gene, closely resemble the human disease in terms of tumor spectrum and hormonal changes [4]. These models have been exploited for therapy-response studies testing novel drugs against neuroendocrine tumors (NETs), providing promising leads for treating MEN1-related NENs [2,4]. They help understand the function of Menin in tumorigenesis, which is conserved from flies to mammals [4].
In conclusion, Men1 plays a crucial role in preventing the development of endocrine tumors as a tumor suppressor gene. The Men1-knockout mouse models have significantly contributed to the understanding of MEN1-associated tumor biology and the exploration of potential therapies for treating MEN1-related diseases, especially neuroendocrine neoplasms [2,4].
References:
1. Thakker, Rajesh V, Newey, Paul J, Walls, Gerard V, Tonelli, Francesco, Brandi, Maria Luisa. 2012. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). In The Journal of clinical endocrinology and metabolism, 97, 2990-3011. doi:10.1210/jc.2012-1230. https://pubmed.ncbi.nlm.nih.gov/22723327/
2. Grozinsky-Glasberg, Simona, Lines, Kate E, Avniel-Polak, Shani, Bountra, Chas, Thakker, Rajesh V. . Preclinical drug studies in MEN1-related neuroendocrine neoplasms (MEN1-NENs). In Endocrine-related cancer, 27, R345-R355. doi:10.1530/ERC-20-0127. https://pubmed.ncbi.nlm.nih.gov/32590358/
3. Brandi, Maria Luisa, Agarwal, Sunita K, Perrier, Nancy D, Valk, Gerlof D, Thakker, Rajesh V. . Multiple Endocrine Neoplasia Type 1: Latest Insights. In Endocrine reviews, 42, 133-170. doi:10.1210/endrev/bnaa031. https://pubmed.ncbi.nlm.nih.gov/33249439/
4. Mohr, Hermine, Pellegata, Natalia S. 2017. Animal models of MEN1. In Endocrine-related cancer, 24, T161-T177. doi:10.1530/ERC-17-0249. https://pubmed.ncbi.nlm.nih.gov/28743793/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.